comparemela.com

Latest Breaking News On - Pharma index - Page 2 : comparemela.com

Indian Pharma Sector Transcationing From Generics-Oriented Hub To Innovation-Driven Pharma Economy: Report

Indian Pharma Sector Transcationing From Generics-Oriented Hub To Innovation-Driven Pharma Economy: Report
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states
India
China
Tara-dougal
Contract-development
Convention-on-pharmaceutical-ingredients
New-delhi
Pharmaceutical-ingredients
Manufacturing-organizations
Pharma-index
Active-pharmaceutical-ingredient
Finished-dosage-form

Indian pharma industry's big pivot: Report reveals sector transitioning from generics to innovation

Ten best bets for Oct series as bulls may charge when Nifty holds 19,800

Overall, the index has still been in the range with 19,750-19,800 likely to act as a crucial resistance as breaking of the same can drive the Nifty50 towards 20,000 mark, whereas 19,500 is expected to be immediate support and 19,200 may be crucial support for the index, experts said

Subash-gangadharan
Piramal-pharma
Ajit-mishra
Ajanta-pharma
Mitesh-karwa
Shrikant-chouhan
Sameet-chavan
Dalmia-bharat
Technical-research-at-religare-broking
Sun-pharmaceutical-industries
Tejas-networks
Head-of-research-retail-at-kotak-securities

Bearish sentiment hits pharmaceutical stocks on profit booking, heavy call writing in Cipla

Despite the broader market s resilience, the pharmaceutical sector exhibits a strong bearish sentiment, characterised by short positions in Glenmark, Cipla, Alkem, and Dr Reddy s

Aurobindo-pharma
Glenmark-pharma
Rajesh-palviya
Zydus-lifesciences-lauras
Sacchitanand-uttekar
Cipla
Bull-call
Vice-president
Data-analysis
Tradebulls-securities
Glenmark-life-sciences-ltd
Nirma-ltd

Nifty scales Summit 20,000: 10 best bets for double-digit returns as bulls keep up the rally

The next targets for the Nifty50 to watch out for would be 20,500-21,000 in the short term, considering the strong momentum sustained through the last seven sessions with participation from bank and IT stocks

Canara
Karnataka
India
Jigars-patel
Rahul-sharma
Sun-pharma
Vidnyan-sawant
Vinay-rajani
Axis-bank
Jm-financial-services
Greenpanel-industries
Sun-pharmaceutical-industries

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.